The growing novel coronavirus, SARS-CoV-2, pandemic has resulted in over 4.6 million infections and 300,000 deaths as of May 20, 2020 according to statistics from the World Health Organization. Identification of effective antiviral agents to combat the SARS-CoV-2 is urgently needed. SARS- CoV-2 binds to their target cells through angiotensin-converting enzyme 2 (ACE2), which is expressed by epithelial cells of the lung, intestine, kidney, and blood vessels. Our research has identified a potent flavonoid Caflanone, with proven antiviral efficacy and potential to serve as an effective treatment and preventative prophylactic.
Vilotos aims to find a cure for novel coronavirus utilizing patent filed technology.